These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35995079)
1. The impact of hormonal contraceptives on anxiety treatments: From preclinical models to clinical settings. Graham BM Front Neuroendocrinol; 2022 Oct; 67():101030. PubMed ID: 35995079 [TBL] [Abstract][Full Text] [Related]
2. The association between estradiol levels, hormonal contraceptive use, and responsiveness to one-session-treatment for spider phobia in women. Graham BM; Li SH; Black MJ; Öst LG Psychoneuroendocrinology; 2018 Apr; 90():134-140. PubMed ID: 29482136 [TBL] [Abstract][Full Text] [Related]
3. The Role of Hormonal and Reproductive Status in the Treatment of Anxiety Disorders in Women. Tang S; Graham BM Adv Exp Med Biol; 2020; 1191():523-541. PubMed ID: 32002944 [TBL] [Abstract][Full Text] [Related]
4. Estradiol levels in women predict skin conductance response but not valence and expectancy ratings in conditioned fear extinction. White EC; Graham BM Neurobiol Learn Mem; 2016 Oct; 134 Pt B():339-48. PubMed ID: 27544848 [TBL] [Abstract][Full Text] [Related]
5. Impact of hormonal contraceptives on sex differences in fear conditioning and fear extinction in PTSD. Bartholomew ME; Rozalski V; Richards A; Gurdock J; Thornton M; Fee C; Lipshitz SL; Metzler TJ; Neylan TC; Inslicht SS Learn Mem; 2022 Sep; 29(9):332-339. PubMed ID: 36206397 [TBL] [Abstract][Full Text] [Related]
6. No pills, more skills: The adverse effect of hormonal contraceptive use on exposure therapy benefit. Raeder F; Heidemann F; Schedlowski M; Margraf J; Zlomuzica A J Psychiatr Res; 2019 Dec; 119():95-101. PubMed ID: 31590077 [TBL] [Abstract][Full Text] [Related]
7. Low estradiol is linked to increased skin conductance, but not subjective anxiety or affect, in response to an impromptu speech task. White EC; Graham BM Psychoneuroendocrinology; 2018 Dec; 98():30-38. PubMed ID: 30092497 [TBL] [Abstract][Full Text] [Related]
8. Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Milad MR; Igoe SA; Lebron-Milad K; Novales JE Neuroscience; 2009 Dec; 164(3):887-95. PubMed ID: 19761818 [TBL] [Abstract][Full Text] [Related]
9. Contribution of estradiol levels and hormonal contraceptives to sex differences within the fear network during fear conditioning and extinction. Hwang MJ; Zsido RG; Song H; Pace-Schott EF; Miller KK; Lebron-Milad K; Marin MF; Milad MR BMC Psychiatry; 2015 Nov; 15():295. PubMed ID: 26581193 [TBL] [Abstract][Full Text] [Related]
10. Hormonal, reproductive, and behavioural predictors of fear extinction recall in female rats. Tang S; Graham BM Horm Behav; 2020 May; 121():104693. PubMed ID: 31981581 [TBL] [Abstract][Full Text] [Related]
11. Estradiol and Progesterone have Opposing Roles in the Regulation of Fear Extinction in Female Rats. Graham BM; Daher M Neuropsychopharmacology; 2016 Feb; 41(3):774-80. PubMed ID: 26156559 [TBL] [Abstract][Full Text] [Related]
12. Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Graham BM; Milad MR Biol Psychiatry; 2013 Feb; 73(4):371-8. PubMed ID: 23158459 [TBL] [Abstract][Full Text] [Related]
13. Rodent models of impaired fear extinction. Singewald N; Holmes A Psychopharmacology (Berl); 2019 Jan; 236(1):21-32. PubMed ID: 30377749 [TBL] [Abstract][Full Text] [Related]
14. Sex differences in conditioned stimulus discrimination during context-dependent fear learning and its retrieval in humans: the role of biological sex, contraceptives and menstrual cycle phases. Lonsdorf TB; Haaker J; Schümann D; Sommer T; Bayer J; Brassen S; Bunzeck N; Gamer M; Kalisch R J Psychiatry Neurosci; 2015 Nov; 40(6):368-75. PubMed ID: 26107163 [TBL] [Abstract][Full Text] [Related]
15. Augmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders. Lebois LAM; Seligowski AV; Wolff JD; Hill SB; Ressler KJ Annu Rev Clin Psychol; 2019 May; 15():257-284. PubMed ID: 30698994 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological enhancement of fear reduction: preclinical models. Graham BM; Langton JM; Richardson R Br J Pharmacol; 2011 Oct; 164(4):1230-47. PubMed ID: 21175588 [TBL] [Abstract][Full Text] [Related]
17. The Melatonergic System in Anxiety Disorders and the Role of Melatonin in Conditional Fear. Huang F; Yang Z; Li CQ Vitam Horm; 2017; 103():281-294. PubMed ID: 28061973 [TBL] [Abstract][Full Text] [Related]
18. Skin Conductance Responses and Neural Activations During Fear Conditioning and Extinction Recall Across Anxiety Disorders. Marin MF; Zsido RG; Song H; Lasko NB; Killgore WDS; Rauch SL; Simon NM; Milad MR JAMA Psychiatry; 2017 Jun; 74(6):622-631. PubMed ID: 28403387 [TBL] [Abstract][Full Text] [Related]
19. Estradiol moderates the relationship between state-trait anxiety and attentional bias to threat in women. Graham BM; Shin G Psychoneuroendocrinology; 2018 Jul; 93():82-89. PubMed ID: 29705576 [TBL] [Abstract][Full Text] [Related]
20. Estradiol modulation of the renin-angiotensin system and the regulation of fear extinction. Parrish JN; Bertholomey ML; Pang HW; Speth RC; Torregrossa MM Transl Psychiatry; 2019 Jan; 9(1):36. PubMed ID: 30696810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]